• China is preparing to test thousands of blood samples in Wuhan to uncover the origins of COVID-19

    2 days ago - By Business Insider

    A cinema in Wuhan is disinfected as the area moved to reopen during the COVID-19 pandemic on July 20, 2020.
    Getty Images
    China is preparing to test thousands of blood samples in Wuhan to uncover the origins of COVID-19.
    Up to 200,000 samples spanning 2019 are kept in the Wuhan Blood Center, CNN reported.
    Wuhan is thought to have been the location of the first COVID-19 infections in humans.
    China is preparing to test thousands of blood samples in Wuhan to uncover the origins of COVID-19, CNN reported on Wednesday. The city in central China's Hubei province is thought to have been the...
    Read more ...

     

  • Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others

    3 days ago - By Business Insider

    Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19.
    Merck
    Merck's COVID-19 pill holds tremendous promise in fighting the pandemic.
    Industry analysts expect Merck to make billions off the not-yet-authorized drug.
    Some countries will be paying $12 per pill, while the US agreed to pay $712 per treatment course.
    Merck is walking a tightrope with its COVID-19 pill, expecting to reap billions in revenue while still making the medicine affordable to the world. The pharmaceutical giant's antiviral program became the first pill...
    Read more ...